Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Cancer stem cells and individualized therapy.

Chumsri S, Phatak P, Edelman MJ, Khakpour N, Hamburger AW, Burger AM.

Cancer Genomics Proteomics. 2007 May-Jun;4(3):165-74. Review.

2.

Cancer stem cells: an approach to identify newer therapeutic targets.

Srivastava S, Krishna S.

J Stem Cells. 2009;4(2):123-31. Review.

PMID:
20232597
3.

Tumor initiating cells.

Bansal N, Banerjee D.

Curr Pharm Biotechnol. 2009 Feb;10(2):192-6. Review.

PMID:
19199951
4.

Experimental chemotherapy and concepts related to the cell cycle.

Tannock IF.

Int J Radiat Biol Relat Stud Phys Chem Med. 1986 Feb;49(2):335-55. Review.

PMID:
3510996
5.

Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.

Shapira A, Livney YD, Broxterman HJ, Assaraf YG.

Drug Resist Updat. 2011 Jun;14(3):150-63. doi: 10.1016/j.drup.2011.01.003. Epub 2011 Feb 16. Review.

PMID:
21330184
6.

"Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management.

Glinsky GV.

J Clin Oncol. 2008 Jun 10;26(17):2846-53. doi: 10.1200/JCO.2008.17.0266. Review.

PMID:
18539963
8.

A self-renewal assay for cancer stem cells.

Clarke MF.

Cancer Chemother Pharmacol. 2005 Nov;56 Suppl 1:64-8. Review.

9.

Cancer stem cell: target for anti-cancer therapy.

Tang C, Ang BT, Pervaiz S.

FASEB J. 2007 Dec;21(14):3777-85. Epub 2007 Jul 11. Review.

PMID:
17625071
10.

Successful therapy must eradicate cancer stem cells.

Dingli D, Michor F.

Stem Cells. 2006 Dec;24(12):2603-10. Epub 2006 Aug 24.

11.

Cancer stem cells: how can we target them?

Ischenko I, Seeliger H, Schaffer M, Jauch KW, Bruns CJ.

Curr Med Chem. 2008;15(30):3171-84. Review.

PMID:
19075661
12.

Identification of side population cells (stem-like cell population) in pediatric solid tumor cell lines.

Komuro H, Saihara R, Shinya M, Takita J, Kaneko S, Kaneko M, Hayashi Y.

J Pediatr Surg. 2007 Dec;42(12):2040-5.

PMID:
18082704
13.

Cancer stem cells and angiogenesis.

Zhao Y, Bao Q, Renner A, Camaj P, Eichhorn M, Ischenko I, Angele M, Kleespies A, Jauch KW, Bruns C.

Int J Dev Biol. 2011;55(4-5):477-82. doi: 10.1387/ijdb.103225yz. Review.

14.

Stem cell origin of cancer and differentiation therapy.

Sell S.

Crit Rev Oncol Hematol. 2004 Jul;51(1):1-28. Review.

PMID:
15207251
15.

Tumor cell contamination in re-infused stem cell autografts: does it have clinical significance?

Shimoni A, K├Ârbling M.

Crit Rev Oncol Hematol. 2002 Feb;41(2):241-50. Review.

PMID:
11856599
16.

Pancreatic cancer stem cells.

Lee CJ, Dosch J, Simeone DM.

J Clin Oncol. 2008 Jun 10;26(17):2806-12. doi: 10.1200/JCO.2008.16.6702. Review.

PMID:
18539958
17.

Induction characterization and targeting of human hematopoietic cancer stem cells.

Zhang M, Dias P, Minev B, Koka PS.

J Stem Cells. 2010;5(1):1-7. doi: jsc.2010.5.1.1.

PMID:
20861923
18.

Cancer stem cells: never Wnt away from the niche.

Malanchi I, Huelsken J.

Curr Opin Oncol. 2009 Jan;21(1):41-6. doi: 10.1097/CCO.0b013e32831d1faf. Review.

PMID:
19125017
19.

Recent advances in cancer stem cells.

Cho RW, Clarke MF.

Curr Opin Genet Dev. 2008 Feb;18(1):48-53. doi: 10.1016/j.gde.2008.01.017. Epub 2008 Mar 19. Review.

PMID:
18356041
20.

Human tumor clonogenic assays: growth conditions and applications.

Salmon SE.

Cancer Genet Cytogenet. 1986 Jan 1;19(1-2):21-8.

PMID:
3940176

Supplemental Content

Support Center